Proto Labs (NYSE:PRLB) Issues Q4 Earnings Guidance

Proto Labs (NYSE:PRLB) issued an update on its fourth quarter earnings guidance on Friday morning. The company provided earnings per share guidance of $0.15-0.18 for the period, compared to the consensus earnings per share estimate of $0.29. The company issued revenue guidance of $115-123 million, compared to the consensus revenue estimate of $120.01 million. Proto Labs also updated its Q4 2024 guidance to 0.280-0.360 EPS.

Proto Labs Stock Performance

PRLB traded down $3.74 during trading on Monday, reaching $34.26. 333,823 shares of the company’s stock were exchanged, compared to its average volume of 191,129. The company’s fifty day moving average price is $28.99 and its 200-day moving average price is $30.44. Proto Labs has a fifty-two week low of $25.75 and a fifty-two week high of $41.87. The firm has a market capitalization of $861.64 million, a PE ratio of 35.83 and a beta of 1.32.

Proto Labs (NYSE:PRLB) last released its earnings results on Friday, November 1st. The industrial products company reported $0.47 EPS for the quarter, topping analysts’ consensus estimates of $0.32 by $0.15. Proto Labs had a net margin of 4.86% and a return on equity of 3.60%. The firm had revenue of $125.60 million during the quarter, compared to analyst estimates of $121.38 million. During the same quarter in the previous year, the business earned $0.31 EPS. The business’s quarterly revenue was down 3.9% compared to the same quarter last year. Research analysts forecast that Proto Labs will post 0.7 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Needham & Company LLC reaffirmed a “hold” rating on shares of Proto Labs in a research report on Friday. Craig Hallum lifted their target price on shares of Proto Labs from $30.00 to $36.00 and gave the stock a “hold” rating in a report on Monday. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $40.00 target price on shares of Proto Labs in a research report on Monday. Finally, StockNews.com cut shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research report on Monday, August 5th. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to MarketBeat.com, Proto Labs has an average rating of “Moderate Buy” and a consensus price target of $40.33.

Insider Activity

In other news, CEO Robert Bodor purchased 3,480 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were purchased at an average cost of $28.68 per share, with a total value of $99,806.40. Following the completion of the purchase, the chief executive officer now owns 80,878 shares of the company’s stock, valued at $2,319,581.04. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a document filed with the SEC, which is available at this link. Insiders own 1.20% of the company’s stock.

Proto Labs Company Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.